GenTel BioSciences' Death

GenTel BioSciences raised a round of funding on March 19, 2012. Investors include Dead.

GenTel BioSciences is engaged in biochip and protein microarray technologies. The company's platform has focused on surface chemistry technologies for the purpose of detecting and measuring proteins. …

Articles about GenTel BioSciences' Death: